Comparing Ovulation Trackers in 2026: Which Fertility Monitor Works Best for You in the UK?

Clearblue stands out as the market leader for fertility monitors thanks to long-standing clinical validation, wide retail availability and an easy-to-understand digital interface that suits users seeking reliability without extensive tech setup. Compared with newer sensor- or app-driven devices on this list, Clearblue’s strength is its trusted hormone-test-based methodology and strong brand recognition, though it can be more consumable-costly over time than some single-purchase wearables. For people prioritizing proven accuracy and convenience in a mainstream fertility monitor, Clearblue remains the default, financially predictable option for many consumers.

Mira Plus is best-in-class for users who want lab-style, quantitative urine hormone tracking: its smartphone-connected analyzer delivers detailed LH and estrogen trend data that produce highly personalized fertile-window predictions, making it technically superior to simple stick-based or BBT-only devices. Compared with other products in this 2026 UK guide (Clearblue, Kegg, Daysy, OvuSense), Mira trades higher upfront and per-test consumable costs for far more granular hormonal insight that can reduce guesswork for people trying to optimise timing or diagnose subtle cycle changes.

Kegg differentiates itself as a non-hormonal, reusable cervical fluid sensor that detects changes in mucus conductivity to identify fertile windows, offering a lower ongoing cost profile because it requires a single purchase rather than regular consumables. Technically it provides an attractive alternative for users who prefer mucus-based detection over hormone tests or basal-temperature devices, though it may be less direct for those who need precise hormone-level confirmation. Compared to Mira or Clearblue, Kegg’s financial advantage is the absence of recurring test-strip costs, while compared to Daysy it can identify fertile days using mucus signals rather than temperature shifts.

Daysy is a market leader for users who prioritise low-maintenance, cost-effective fertility tracking: a one-time purchase provides ongoing basal-body-temperature-based predictions with no regular consumable expense, giving it a clear financial advantage over test-stick or subscription models like Mira or some Clearblue offerings. Technically it is simpler and less granular than Mira's quantitative hormone analysis or OvuSense's continuous core-temperature monitoring, but for many people with regular cycles Daysy delivers reliable, easy-to-use day-to-day guidance and long-term value.

OvuSense positions itself as the clinical-grade ovulation confirmation solution by using a continuous intravaginal core-temperature sensor to detect ovulation and measure luteal-phase length in real time, making it particularly valuable for irregular cycles or users working with fertility clinicians. Although it typically has a higher upfront cost and requires overnight sensor use compared with external BBT devices like Daysy or disposable stick approaches such as Clearblue, OvuSense provides retrospective, high-confidence ovulation confirmation that complements predictive tools like Mira and cervix-based options like Kegg.